作者
Johan L.K. Van Hove,Marisa W. Friederich,Dana Strode,Roxanne A. Van Hove,Kristen Campbell,Rohit Sharma,Hardik Shah,Jane Estrella,Linda Gabel,Simon Horslen,Rohit Kohli,Mark A. Lovell,Alexander Miethke,Jean P. Molleston,René Romero,James E. Squires,Estella M. Alonso,Maria Oliva‐Hemker,Binita M. Kamath,Kathleen M. Loomes,Philip Rosenthal,Krupa R. Mysore,Laurel Cavallo,Pamela L. Valentino,John C. Magee,Shikha S. Sundaram,Ronald J. Sokol
摘要
Mitochondrial hepatopathies (MHs) are primary mitochondrial genetic disorders that can present as childhood liver disease. No recognized biomarkers discriminate MH from other childhood liver diseases. The protein biomarkers growth differentiation factor 15 (GDF15) and fibroblast growth factor 21 (FGF21) differentiate mitochondrial myopathies from other myopathies. We evaluated these biomarkers to determine if they discriminate MH from other liver diseases in children.
PDF的下载单位、IP信息已删除
(2025-6-4)
无极微光
cdercder
伶俐妙海
Copyright
yjh123
phdbio
Nexus
潇洒的惋清
Nole
huang
arniu2008
sagitar
行走的荷尔蒙
tiptip
kimyb
Criminology34
Kao
OK
dew
烂漫的碧玉
皖公网安备34019202002308
